Identity and synonyms
Catalog label is recorded; analytical identity and equivalence are not established.
Nonpeptide agent · Vitamin or precursor
Detailed molecular class: Nonpeptide agent; see mechanism for subtype
Supplied sequence or chemical reference
PubChem CID: 131204
Molecular formula: C9H19NO4
IUPAC: (2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide
Source: PC-DEXPANTHENOL
Database chemical reference; does not certify supplier vial, salt, isomer or formulation.
Mechanism
Pantothenic-acid alcohol analogue/precursor, not a peptide; dosage form defines use.
Evidence and critical reading
Reported scientific and empirical uses
Replacement and nutritional context · Skin, hair and cosmetics
Topical skin-care uses; do not extrapolate a cream to a systemic vial or every B5 product.
Human evidence
B5 requirements/topical-product data are not an injectable dexpanthenol hair-growth trial.
Preclinical evidence
Do not equate mechanism, cell culture or animal work with a clinical outcome. The specific level is detailed in the evidence assessment.
Critical reading and limitations
B5 requirements/topical-product data are not an injectable dexpanthenol hair-growth trial.
B5 requirements/topical-product data are not an injectable dexpanthenol hair-growth trial.
Source-specific regimens
Descriptive source observations, not individual recommendations.
Regulatory product labeling
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Human-study exposure
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Empirical handbook
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Regulation and safety
Jurisdiction-specific regulatory context
This record does not verify FDA/EMA authorization of the commercial identity. Where a specific medicine/product exists, jurisdiction/indication are detailed in cited sources; they do not transfer to supplier material.
Adverse effects and unknowns
Irritation/sensitization depends on product/excipients. No systemic regimen or blend interactions were defined here.
Contraindications
A complete list must match the exact authorized product. For experimental materials without verified human labeling, a complete contraindication set is not established here. No list does not mean safety.
Interactions
Separate documented interaction, pharmacologic plausibility and unknown interaction. Absence of a blend trial does not establish compatibility.
Studies and trials
Selected studies
No selected studies are attributed in this record.
Trials attributed in the package
No trials are attributed in this record.
Trial registration does not establish efficacy or validate commercial material.
Query candidates; attribution pending
Dexpanthenol · 56 unfiltered query results, not authenticated trials
Query verification: October 16, 2026
Exact phrase intervention query; first three most recently updated records, not exhaustive. Aliases may be missed and heterogeneous products may appear. The total is the unfiltered registry query count, not authenticated trials. Source-integrity holds are excluded from ordinary listings.
View trial registry queryNCT07431385 · Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant TreatmentRegistry status: CompletedLast update posted: September 25, 2026Query verification: October 16, 2026
NCT06210373 · Assessment of Efficacy and Safety of the Use of Two Eye Gel Products Containing 5% Dexpanthenol in Patients With Moderate to Severe Dry Eye SyndromeRegistry status: CompletedLast update posted: September 21, 2026Query verification: October 16, 2026
NCT07767448 · Skin Changes From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse EventsRegistry status: Not yet recruitingLast update posted: September 11, 2026Query verification: October 16, 2026
Source issues and references
References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.
- ODS-PANTOTHENIC
October 16, 2026
- PC-DEXPANTHENOL
PubChem dexpanthenol (CID 131204)
October 16, 2026